Insider: Ho Carole Chief Medical Officer - Denali Therapeutics Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 216,585 | 198,777 | 415,362 |
| Value | $4,262,392.80 | $3,911,931.36 | $8,174,324.16 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/13/2025 | DDS | 806 | Direct | COM | $14.64 | $11,799.84 | 216,585 |
| 08/12/2025 | DDS | 2,937 | Direct | COM | $13.58 | $39,884.46 | 217,391 |
| 01/07/2025 | DDS | 2,907 | Direct | COM | $20.81 | $60,494.67 | 175,673 |
| 01/06/2025 | DDS | 12,255 | Direct | COM | $20.22 | $247,796.10 | 178,580 |
| 08/21/2024 | DDS | 14,098 | Direct | COM | $24.41 | $344,132.18 | 124,717 |
| 08/21/2024 | DDS | 5,907 | Direct | COM | $24.96 | $147,438.72 | 118,810 |
| 08/20/2024 | DDS | 2,453 | Direct | COM | $23.79 | $58,356.87 | 138,815 |
| 08/13/2024 | DDS | 2,337 | Direct | COM | $22.89 | $53,493.93 | 141,268 |
| 02/14/2024 | DDS | 1,405 | Direct | COM | $17.79 | $24,994.95 | 143,605 |
| 02/13/2024 | DDS | 2,784 | Direct | COM | $17.29 | $48,135.36 | 145,010 |
| 01/10/2024 | DDS | 4,668 | Direct | COM | $19.02 | $88,785.36 | 147,794 |
| 01/05/2024 | DDS | 9,972 | Indirect | COM | $19.43 | $193,755.96 | 198,777 |
| 08/23/2023 | DDS | 2,522 | Indirect | COM | $23.22 | $58,560.84 | 182,809 |
| 08/21/2023 | DDS | 2,478 | Indirect | COM | $22.60 | $56,002.80 | 185,331 |
| 08/14/2023 | DDS | 2,768 | Indirect | COM | $23.79 | $65,850.72 | 182,809 |
| 08/10/2023 | DDS | 2,857 | Indirect | COM | $24.15 | $68,996.55 | 185,577 |
| 02/15/2023 | DDS | 1,476 | Indirect | COM | $29.40 | $43,394.40 | 182,809 |
| 02/13/2023 | DDS | 2,548 | Indirect | COM | $30.10 | $76,694.80 | 184,285 |
| 02/10/2023 | DDS | 818 | Indirect | COM | $29.80 | $24,376.40 | 179,365 |
| 02/08/2023 | DDS | 1,521 | Indirect | COM | $30.88 | $46,968.48 | 180,183 |
| 01/09/2023 | DDS | 1,459 | Indirect | COM | $28.48 | $41,552.32 | 177,454 |
| 01/06/2023 | DDS | 1,451 | Indirect | COM | $28.67 | $41,600.17 | 178,913 |
| 01/05/2023 | DDS | 2,636 | Indirect | COM | $28.44 | $74,967.84 | 180,364 |
| 01/04/2023 | DDS | 2,913 | Indirect | COM | $28.69 | $83,573.97 | 175,500 |
| 08/23/2022 | DDS | 2,424 | Indirect | COM | $31.98 | $77,519.52 | 170,663 |
| 1 2 3 4 Next Last You are at page 1 of 4 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research